Business Context and Reporting Period
This summary covers the Form 10-Q filed by Apollo Investment Corporation (AIC) for the quarter ended June 30, 2015. AIC is a closed-end, externally managed business development company (BDC) and regulated investment company (RIC) focused on generating current income and capital appreciation through debt and equity investments in private middle-market companies. As of June 30, 2015, the company had 236,741,351 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 2015 | Q2 2014 |
|---|---|---|
| Total Investment Income | $101.7 million | $102.6 million |
| Net Investment Income | $51.0 million | $53.6 million |
| Net Realized Gain (Loss) | ($80.9 million) | ($13.3 million) |
| Net Change in Unrealized Gain (Loss) | $36.3 million | $24.4 million |
| Net Increase in Net Assets from Operations | $6.4 million | $64.6 million |
| Earnings Per Share (Basic & Diluted) | $0.03 | $0.27 |
| Net Asset Value (NAV) per Share | $8.01 | $8.18 (Beginning of Period) |
| Total Debt Outstanding | $1.39 billion | $1.50 billion (Beginning of Period) |
| Cash and Cash Equivalents | $12.9 million | $11.6 million (End of Q2 2014) |
Material Changes vs. Prior Period
- Significant Decline in Net Income: Net increase in net assets from operations dropped from $64.6 million in Q2 2014 to $6.4 million in Q2 2015. This was primarily driven by a substantial increase in net realized losses.
- Realized Losses: Net realized losses surged to $80.9 million in Q2 2015 compared to $13.3 million in the prior year. Major contributors to these losses included exits from PlayPower Holdings Inc. ($42.9 million loss), Molycorp, Inc. ($22.1 million loss), and PetroBakken Energy Ltd. ($9.0 million loss).
- Unrealized Gains: Net change in unrealized gains increased to $36.3 million, partially offsetting realized losses. Significant unrealized gains were recorded for PlayPower Holdings Inc. ($21.8 million) and Molycorp, Inc. ($20.4 million), reflecting reversals of prior losses upon exit.
- Expense Increases: Net expenses rose to $50.7 million from $49.0 million. Interest and other debt expenses increased by $3.5 million due to the issuance of 2025 Notes in March 2015, raising the total annualized interest cost to 5.85% from 4.87%.
- Portfolio Composition: The portfolio shifted slightly, with secured debt comprising 64% of fair value (up from 60%) and unsecured debt decreasing to 10% (down from 14%).
Guidance, Outlook, and Risks
- Dividends: The Board declared a dividend of $0.20 per share for the first fiscal quarter of 2016, payable October 6, 2015. The company maintains an "opt-out" dividend reinvestment plan.
- Share Repurchase: On August 5, 2015, the company adopted a plan to repurchase up to $50 million of its common stock.
- Debt Facility: The Senior Secured Facility was amended in April 2015, increasing commitments to $1.31 billion and extending maturity to April 2020. As of June 30, 2015, $1.01 billion of capacity remained unused.
- Legal Proceedings: AIC is a defendant in a lawsuit filed by the bankruptcy trustee of DSI Renal Holdings, alleging fraudulent conveyance. The complaint seeks approximately $41 million in damages from AIC. The company intends to vigorously defend itself and has filed a motion to dismiss.
- Non-Accrual Status: As of June 30, 2015, 2.5% of total investments at amortized cost were on non-accrual status, an increase from 1.3% at the end of the prior fiscal year.
Investor Verification Checklist
- Realized Loss Drivers: Verify the specific circumstances surrounding the $80.9 million in realized losses, particularly the exits from PlayPower Holdings and Molycorp, to assess if these were isolated events or indicative of broader portfolio credit deterioration.
- Debt Covenants: Confirm continued compliance with the Senior Secured Facility covenants, specifically the asset coverage ratio (minimum 2.0:1.0) and minimum stockholders' equity requirements, given the recent debt issuance and market volatility.
- PIK Income Sustainability: Review the $8.1 million in Payment-in-Kind (PIK) income recognized. Assess the collectability of this non-cash income and its impact on the company's ability to meet RIC distribution requirements without cash inflows.
- Legal Exposure: Monitor the status of the DSI Renal Holdings litigation to determine potential liability exposure and its impact on future financial statements.
- Share Repurchase Execution: Track the execution of the new $50 million share repurchase plan to evaluate management's confidence in the stock price and capital allocation strategy.